Treatment with LPS of NOD mice aggravated the Sjögren’s Syndrome-like manifestations, induced expansion of MDSCs, promoted the activation of (NLRP3) inflammasome and production of IL-1β and IL-18 (38). The gene discussed is IL1B; the disease is Sjogren syndrome.